pivalyloxymethyl butyrate has been researched along with Leukemia, Promyelocytic, Acute in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aviram, A; Nudelman, A; Rabizadeh, E; Rephaeli, A; Ruse, M; Shaklai, M; Zimrah, Y | 1 |
| Aviram, A; Nudelman, A; Rephaeli, A; Shaklai, M; Zimrah, Y | 1 |
| Eisenbach, L; Nudelman, A; Rabizadeh, E; Rephaeli, A; Shaklai, M | 1 |
3 other study(ies) available for pivalyloxymethyl butyrate and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
Novel anticancer prodrugs of butyric acid. 2.
Topics: Animals; Antineoplastic Agents; Butyrates; Cell Differentiation; Cell Division; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Molecular Structure; Neoplasm Metastasis; Prodrugs; Tumor Cells, Cultured | 1992 |
Comparison between the effect of butyric acid and its prodrug pivaloyloxymethylbutyrate on histones hyperacetylation in an HL-60 leukemic cell line.
Topics: Acetylation; Aniline Compounds; Butyrates; Butyric Acid; Histones; Leukemia, Promyelocytic, Acute; Organophosphorus Compounds; Prodrugs; Tumor Cells, Cultured | 1994 |
Rapid alteration of c-myc and c-jun expression in leukemic cells induced to differentiate by a butyric acid prodrug.
Topics: Antineoplastic Agents; Butyrates; Cell Differentiation; Cell Division; Gene Expression Regulation; Humans; Leukemia, Promyelocytic, Acute; Prodrugs; Proto-Oncogene Proteins c-jun; Proto-Oncogene Proteins c-myc; Tumor Cells, Cultured | 1993 |